Literature DB >> 7666466

Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.

C Bokemeyer, H J Schmoll, M A Kuczyk, J Beyer, W Siegert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7666466     DOI： 10.1093/jnci/87.1.58

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

Review 1.  Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters.

Authors:  C Bokemeyer; M A Kuczyk; J Serth; J T Hartmann; H J Schmoll; U Jonas; L Kanz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Diagnosis and treatment of patients with testicular germ cell cancer.

Authors:  J T Hartmann; L Kanz; C Bokemeyer
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

3.  Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.

Authors:  J Wierecky; C Kollmannsberger; I Boehlke; M Kuczyk; J Schleicher; N Schleucher; B Metzner; L Kanz; J T Hartmann; C Bokemeyer
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-31       Impact factor: 4.553

4.  Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.

Authors:  Zhao-Jie Lv; Song Wu; Pei Dong; Kai Yao; Yin-Yin He; Yao-Ting Gui; Fang-Jian Zhou; Zhuo-Wei Liu; Zhi-Ming Cai
Journal:  Asian J Androl       Date:  2013-05-20       Impact factor: 3.285

Review 5.  Acute leukemia following treatment of malignant glioma.

Authors:  J R Perry; M T Brown; J P Gockerman
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

6.  Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients.

Authors:  Regan Howard; Ethel Gilbert; Charles F Lynch; Per Hall; Hans Storm; Eric Holowaty; Eero Pukkala; Froydis Langmark; Magnus Kaijser; Michael Andersson; Heikki Joensuu; Sophie D Fossa; James M Allan; Lois B Travis
Journal:  Ann Epidemiol       Date:  2008-05       Impact factor: 3.797

7.  Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.

Authors:  A Gerl; C Clemm; N Schmeller; R Hartenstein; R Lamerz; W Wilmanns
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

Review 8.  Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor.

Authors:  Sachiko Ezoe
Journal:  Int J Environ Res Public Health       Date:  2012-07-10       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.